FUS pathology in basophilic inclusion body disease - Wikidata - awgldk - TriplyDB

FUS pathology in basophilic inclusion body disease

FUS pathology in basophilic inclusion body disease

http://www.wikidata.org/entity/Q28261473

about

The genetics and neuropathology of frontotemporal lobar degeneration ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia A loss of FUS/TLS function leads to impaired cellular proliferation Early lethality and neuronal proteinopathy in mice expressing cytoplasm-targeted FUS that lacks the RNA recognition motif.FUS transgenic rats develop the phenotypes of amyotrophic lateral sclerosis and frontotemporal lobar degeneration Pathogenesis of FUS-associated ALS and FTD: insights from rodent models Transportin1: a marker of FTLD-FUS FUS Interacts with HSP60 to Promote Mitochondrial Damage Frontotemporal Dementia.Clinical characterization of bvFTD due to FUS neuropathology.Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion.Recruitment into stress granules prevents irreversible aggregation of FUS protein mislocalized to the cytoplasm Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS FUS immunogold labeling TEM analysis of the neuronal cytoplasmic inclusions of neuronal intermediate filament inclusion disease: a frontotemporal lobar degeneration with FUS proteinopathy.FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration.Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update.Distinct pathological subtypes of FTLD-FUS.Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration.Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management.Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations.Poly-A binding protein-1 localization to a subset of TDP-43 inclusions in amyotrophic lateral sclerosis occurs more frequently in patients harboring an expansion in C9orf72 FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis.FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease.Fus gene mutations in familial and sporadic amyotrophic lateral sclerosis.Functions of FUS/TLS from DNA repair to stress response: implications for ALS.Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules Knockdown of the Drosophila fused in sarcoma (FUS) homologue causes deficient locomotive behavior and shortening of motoneuron terminal branches.Caudate atrophy on MRI is a characteristic feature of FTLD-FUS The spectrum and severity of FUS-immunoreactive inclusions in the frontal and temporal lobes of ten cases of neuronal intermediate filament inclusion disease.Familial behavioral variant frontotemporal dementia associated with astrocyte-predominant tauopathy Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine.A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies Spatial patterns of FUS-immunoreactive neuronal cytoplasmic inclusions (NCI) in neuronal intermediate filament inclusion disease (NIFID).Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutation Monomethylated and unmethylated FUS exhibit increased binding to Transportin and distinguish FTLD-FUS from ALS-FUS.ALS mutations in TLS/FUS disrupt target gene expression.

P2860

Q24615201-E86B7BDF-5965-4278-944C-BD7C060CC11D Q24630100-CD30627C-77B2-41D8-A81E-C36722BA94B8 Q24634807-ACD2DDB5-4AB4-4AA1-89B8-74431DE05080 Q26768648-6FD9155D-5DDA-419A-8D4E-97870C294E61 Q26782984-186A7C02-C92C-4772-8294-950CB3B260A2 Q27331026-4118248A-411E-4FF0-BB52-53B92F9FC30D Q27334411-FD7EB6D5-141E-4CA0-90A7-91A21BE6359C Q27342067-5B3FDBED-A065-4A40-A6F8-B81874B5037D Q28067147-D78485B3-A3A3-42A3-A62E-0737577FDD67 Q28245695-BCF509B6-8F07-40B3-8A9A-476DC125EED4 Q28547727-CD830A3B-4EE3-45D0-822B-212EF0B34A47 Q30234793-97FA876C-2BA8-4CA3-B94A-C6045D9FE13F Q30505752-03F144D6-7A8E-4141-A0C0-3B81C5E5F051 Q30532680-083EAC7A-2DB6-4EEF-A777-90929BD809AA Q30559680-475FDFC7-C5B3-4CB2-91ED-3F9FA844E64C Q33889532-8ADF3D5D-9B57-4038-81EB-DBCE86DC71F0 Q33908722-7E0C25E8-4A43-4D84-A31C-E5637DF31E46 Q33922335-855C3E4D-DBBA-42D2-8D0A-0CA9EEAB01DF Q34020227-A467C239-5F0A-452C-BAFC-8FEE7F6111F2 Q34024578-5D512201-FD99-4EC6-89DC-E762C97EE75C Q34028511-160E1BCE-6095-45C8-BC4A-F048C6880EF4 Q34046590-98873EC3-6946-497A-B853-6EFCA4BD6542 Q34099212-AFA1A685-A686-4159-BAC1-7986B9342610 Q34109160-560C6BE4-E6E4-491A-9085-5D4AE6D7A694 Q34118590-021BFA10-9235-431C-BC76-DAD2CDE5A676 Q34209561-03630796-EEA7-43C0-8F26-06BF6500B639 Q34263380-DE5E61F7-7858-49FE-B5DD-BFA982AF16D2 Q34265540-A34ED524-DC76-4F22-86AC-FE759A261199 Q34305789-0C7267DB-CB1B-4455-B6E7-45E81F01CFBF Q34308339-25379716-0AA1-4EBC-8690-9564BEE47F30 Q34314477-6AD69ABE-DC95-4FA3-8E67-5B5BC99E79B5 Q34340214-A4E2ADE3-84C4-4AF0-9E3E-A694941E55E2 Q34557808-DBB4B777-AEA0-4C5C-9F3E-CAD52A2F0E18 Q35196395-04850734-B688-49D8-AB45-C4489D7AE30A Q35204586-1BBF1E94-8F70-44BA-A9C4-D7DD84FA5A63 Q35206942-C29361A7-4E73-403D-BCF6-7B731729C874 Q35421505-72ADF5F9-5B07-4C5B-BB31-ECC435013387 Q35869162-B8A2A271-3D46-47D4-BE0A-6EE9D7EB8A40 Q35928701-4E40510E-A641-4FAC-A2CC-A7F33DF11189 Q36032446-15D62E66-3981-4FA6-A218-14AD1759B9E0

P2860

FUS pathology in basophilic inclusion body disease

http://www.wikidata.org/entity/Q28261473

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

FUS pathology in basophilic inclusion body disease

@ast

FUS pathology in basophilic inclusion body disease

@en

FUS pathology in basophilic inclusion body disease

@nl

type

label

FUS pathology in basophilic inclusion body disease

@ast

FUS pathology in basophilic inclusion body disease

@en

FUS pathology in basophilic inclusion body disease

@nl

prefLabel

FUS pathology in basophilic inclusion body disease

@ast

FUS pathology in basophilic inclusion body disease

@en

FUS pathology in basophilic inclusion body disease

@nl

P1433

Q28261473-8A14AB94-528F-4CA4-996B-BC8EE1380720

P1476

Q28261473-45FDAE0A-4947-4352-BCCD-2B14411767D6

P2093

Q28261473-14E00E85-0205-4BAD-96B7-FB5B6D3C16E7

Q28261473-532F9273-22E1-4050-97AF-A48FC8D86971

Q28261473-85C6E446-C736-4F2A-8CE6-567C55203B67

Q28261473-8E793E57-1A9D-49BC-A742-4A4AC9FBD93F

Q28261473-BC5104A0-CED7-4D2B-AC9F-3A26C24901BB

Q28261473-DB0BDAE9-949E-4414-8E00-D39216187C50

Q28261473-E8372CC1-7D00-474E-A798-4964E83CD158

P2860

Q28261473-508FC54B-AA07-4D55-86EB-69947F6C0D22

Q28261473-9254EDC8-55F1-40DA-A96F-487410554638

Q28261473-C06A03B9-8F6A-485B-8CD8-350AC27CE6F9

Q28261473-D5157640-49B3-410A-A9AD-E744F6A79E87

Q28261473-E9405AFD-126F-4EE0-BFF6-CBFF821E2739

Q28261473-E977807F-876F-41B0-8BE5-A8C4D13DA7EC

P2888

Q28261473-40464ED2-40C0-415E-9F9A-5B558289E410

P304

Q28261473-06D8BF11-E739-4DA0-9C50-CBDD0E735BDE

P31

Q28261473-684DB8E2-BF93-45BF-B5DB-4B612BF98AC2

P3181

Q28261473-83CD5EAD-0DFB-438F-BDAF-513BC7056BB0

P356

Q28261473-3C336EF5-E2E0-40C5-AE9F-09356FA118CD

P407

Q28261473-1236EEAD-E9A2-463B-A773-A94C07A8B7F6

P433

Q28261473-5A6A0E9E-53EF-4DEB-A66B-82E1A515629C

P478

Q28261473-46F44AFA-435F-4FA7-9149-BB23D42C6F04

P50

Q28261473-29F89B11-B5E1-41F7-8FC7-FDF809DE26D4

P577

Q28261473-06EA8C47-F83C-4DDE-8E4A-661A15A6319B

P6179

Q28261473-C51B5AD4-B0DD-4D05-8435-3231C5972AE4

P698

Q28261473-3CEC92BE-EA06-4241-AB15-71F76FB0D3A8

P921

Q28261473-4b7d061a-5d47-4030-a7d6-90b46accff3e

P3181

P356

S00401-009-0598-9

P1433

Acta Neuropathologica

P1476

FUS pathology in basophilic inclusion body disease

@en

P2093

David G Munoz

http://www.w3.org/2001/XMLSchema#string

Hirofumi Kusaka

http://www.w3.org/2001/XMLSchema#string

Ian R Mackenzie

http://www.w3.org/2001/XMLSchema#string

Kenji Ishihara

http://www.w3.org/2001/XMLSchema#string

Osamu Yokota

http://www.w3.org/2001/XMLSchema#string

Seishi Terada

http://www.w3.org/2001/XMLSchema#string

Shigetoshi Kuroda

http://www.w3.org/2001/XMLSchema#string

P2860

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

Genetics of familial and sporadic amyotrophic lateral sclerosis.

Pick's disease: a case clinically resembling amyotrophic lateral sclerosis.

Amyotrophic lateral sclerosis with ophthalmoplegia and multisystem degeneration in patients on long-term use of respirators.

Sporadic juvenile amyotrophic lateral sclerosis. A clinicopathological study of a case with neuronal cytoplasmic inclusions containing RNA.

Distribution of cerebral cortical lesions in Pick's disease with Pick bodies: a clinicopathological study of six autopsy cases showing unusual clinical presentations.

P2888

s00401-009-0598-9

P304

617-27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2497126

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S00401-009-0598-9

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P50

Manuela Neumann

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1025282491

http://www.w3.org/2001/XMLSchema#string

P698

19830439

http://www.w3.org/2001/XMLSchema#string

P921